Geode Capital Management
TBIO

Geode Capital Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Geode Capital Management’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,209,853
Closed -$33.3M – 4899
2021
Q2 		$33.3M Buy
1,209,853
+48,484
+4% +$953K ﹤0.01% 1636
2021
Q1 		$19.1M Buy
1,161,369
+101,420
+10% +$2.31M ﹤0.01% 1905
2020
Q4 		$19.5M Buy
1,059,949
+60,195
+6% +$1.08M ﹤0.01% 1738
2020
Q3 		$13.6M Buy
999,754
+180,044
+22% +$2.78M ﹤0.01% 1776
2020
Q2 		$14.7M Buy
819,710
+234,446
+40% +$3.54M ﹤0.01% 1708
2020
Q1 		$5.83M Buy
585,264
+38,683
+7% +$317K ﹤0.01% 2053
2019
Q4 		$4.45M Buy
546,581
+37,577
+7% +$347K ﹤0.01% 2528
2019
Q3 		$5.04M Buy
509,004
+114,060
+29% +$1.08M ﹤0.01% 2374
2019
Q2 		$4.99M Buy
394,944
+151,190
+62% +$1.59M ﹤0.01% 2394
2019
Q1 		$2.48M Buy
243,754
+126,322
+108% +$969K ﹤0.01% 2720
2018
Q4 		$880K Buy
117,432
+68,300
+139% +$500K ﹤0.01% 3152
2018
Q3 		$491K Buy
+49,132
New +$572K ﹤0.01% 3470

Geode Capital Management's TBIO Position: Q3 2021 in Review

Geode Capital Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 1,209,853 shares — an estimated $33.3M sold.

Geode Capital Management first reported a position in TBIO in Q3 2018 and held it in 12 quarters. The position peaked at $33.3M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Geode Capital Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Geode Capital Management sold 1,209,853 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $33.3M.
  • Geode Capital Management first reported a position in Translate Bio, Inc. Common Stock in Q3 2018 and held it in 12 quarters.
  • Geode Capital Management's Translate Bio, Inc. Common Stock position peaked at $33.3M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.